NCT05777525

Brief Summary

Mycosis is defined as a fungal infection caused by the implantation of etiological agents that compromises the dermis and subcutaneous tissue. Dermatophytosis is a fungal infection caused by dermatophytes, being the main cause of superficial mycoses and constituting an important public health problem. The production or development of infections is due in any case to the loss of ability to protect the exterior of the skin epidermis and, in the case of nails, to the fact that the nail apparatus does not have cell-mediated immunity effective, thus being more susceptible to infection than other parts of the skin. Although these infections can be bacterial, fungal, or viral, the investigators will focus on fungal infections. There are numerous studies that suggest the suitability of EOs as an alternative treatment for fungal infections. Due to this, in this project the investigators will analyze one of the most important infections within the podiatric health of the population, in terms of its incidence, pathogenesis, diagnostic methods, etc., and for this our research will be focused on examining whether there is improvements in the skin of patients with dermatophytosis treated with cream enriched with natural oils, in our case tea tree oil, verified by ultrasound.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
49

participants targeted

Target at below P25 for phase_3

Timeline
Completed

Started Feb 2023

Shorter than P25 for phase_3

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 11, 2023

Completed
2 days until next milestone

First Submitted

Initial submission to the registry

February 13, 2023

Completed
1 month until next milestone

First Posted

Study publicly available on registry

March 21, 2023

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 15, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 15, 2023

Completed
Last Updated

December 15, 2023

Status Verified

December 1, 2023

Enrollment Period

9 months

First QC Date

February 13, 2023

Last Update Submit

December 7, 2023

Conditions

Keywords

Echographyessential oilsdermatophytosisnatural treatmentultrasonography

Outcome Measures

Primary Outcomes (3)

  • Appearance of the skin through the use of ultraviolet light through the processing of photographs obtained

    Data collection with Visiopor camera. Measurement unit: occupied area

    3 months

  • Skin thickness measured in millimeters through images obtained by ultrasound

    Data collection with ultrasound. Measurement unit: millimeters

    3 months

  • Taking mycological samples for subsequent cultivation on saboureaud agar

    take mycological samples to check for infection. Measurement unit: positive/negative

    3 months

Study Arms (4)

Echography

NO INTERVENTION

Ultrasound skin measurements will be taken before and after the enriched cream treatment.

"Visiopor PP-34 camera"

NO INTERVENTION

Measurements of the skin will be taken by "Visiopor PP-34" camera before and after the treatment with enriched cream.

Mycological culture

NO INTERVENTION

Skin samples will be taken and analyzed by mycological culture before and after treatment with enriched cream

treatment application

EXPERIMENTAL

The essential oil enriched cream will be applied to study participants.

Combination Product: application of cream "La Chinata"

Interventions

application of cream enriched with essential oil

treatment application

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • who is in the age range
  • consent signature accepted
  • not have allergies to the treatment
  • not have chronic skin diseases

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Raquel Mayordomo Acevedo

Plasencia, Cáceres, 10600, Spain

Location

MeSH Terms

Conditions

Tinea

Condition Hierarchy (Ancestors)

DermatomycosesMycosesBacterial Infections and MycosesInfectionsSkin Diseases, InfectiousSkin DiseasesSkin and Connective Tissue Diseases

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
CROSSOVER
Model Details: Parallel treatment design and double-blind
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Professor

Study Record Dates

First Submitted

February 13, 2023

First Posted

March 21, 2023

Study Start

February 11, 2023

Primary Completion

November 15, 2023

Study Completion

November 15, 2023

Last Updated

December 15, 2023

Record last verified: 2023-12

Data Sharing

IPD Sharing
Will not share

Locations